Use of preoperative performance status and hemoglobin concentration to predict overall survival for patients aged ≥75 years after radical cystectomy for treatment of bladder cancer

International Journal of Clinical Oncology

Volumn 21, Issue 1, 2016, Pages 139-147

  Hara, Takahiko ^a,b   Matsuyama, Hideyasu ^a   Kamiryo, Yoriaki ^c   Hayashida, Shigeaki ^d   Yamamoto, Norio ^e   Nasu, Takahito ^d   Joko, Keiji ^f   Baba, Yoshikazu ^g   Suga, Akinobu ^h   Yamamoto, Mitsutaka ⁱ   Aoki, Akihiko ^b   Takai, Kimio ^j   Yoshihiro, Satoru ^k   Konishi, Motohiko ^l   Sakano, Sigeru ^m   Imoto, Katsuhiko ⁿ   Tei, Yasuhide ^o   Yamaguchi, Shiro ^p   Yano, Seiji ^q  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Masuda Red Cross Hospital   (Japan)

^c Department of Urology   (Japan)

^d Tokuyama Central Hospital   (Japan)

^e Tokuyama Medical Association Hospital   (Japan)

^f Saiseikai Yamaguchi General Hospital   (Japan)

^g Shuto General Hospital   (Japan)

^h YAMAGUCHI RED CROSS HOSPITAL   (Japan)

ⁱ Yamaguchi Grand Medical Center   (Japan)

^j Saiseikai Shimonoseki General Hospital   (Japan)

^k Shimonoseki City Hospital   (Japan)

^l Shunan City Shin Nanyo Hospital   (Japan)

^m KOKURA MEMORIAL HOSPITAL   (Japan)

ⁿ Department of Urology   (Japan)

^o Kanmon Medical Center   (Japan)

^p Shimonoseki Medical Center   (Japan)

^q Ogori Daiichi General Hospital   (Japan)

more..

Author keywords

Bladder cancer; Overall survival; Patient selection; Radical cystectomy

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CALCIUM; HEMOGLOBIN; LACTATE DEHYDROGENASE;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLADDER CANCER; CALCIUM BLOOD LEVEL; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL FEATURE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTECTOMY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; ILEAL CONDUIT; INCIDENCE; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; OVERALL SURVIVAL; PELVIS LYMPHADENECTOMY; PEROPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL PREDICTION; TREATMENT OUTCOME; URETEROSTOMY; URINARY DIVERSION; VERY ELDERLY; WOUND COMPLICATION; ADVERSE EFFECTS; AGE; HEALTH STATUS; LYMPH NODE DISSECTION; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; SURVIVAL RATE; URINARY BLADDER NEOPLASMS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CYSTECTOMY; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HEMOGLOBINS; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; URINARY BLADDER NEOPLASMS; URINARY DIVERSION;

EID: 84957840676     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-015-0857-9     Document Type: Article

References (21)

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10–29
2. Prout GR Jr, Wesley MN, Yancik R et al (2005) Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population-based study. Cancer 104:1638–1647
3. Yuge K, Kikuchi E, Matsumoto K et al (2011) Could patient age influence tumor recurrence rate in non-muscle-invasive bladder cancer patients treated with BCG immunotherapy? Jpn J Clin Oncol 41:565–570
4. Rodel C, Grabenbauer GG, Kuhn R et al (2002) Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J Clin Oncol 20:3061–3071
5. Evers PD, Logan JE, Sills V et al (2014) Karnofsky performance status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma. World J Urol 32:385–391
6. Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383
7. Koppie TM, Serio AM, Vickers AJ et al (2008) Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer 112:2384–2392
8. Clavien PA, Barkun J, De Oliveira ML et al (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250:187–196
9. Clavien PA, Sanabria JR, Strasberg SM (1992) Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery 111:518–526
10. Martinez-Velilla N, Cambra-Contin K, Ibanez-Beroiz B (2014) Comorbidity and prognostic indices do not improve the 5-year mortality prediction of components of comprehensive geriatric assessment in hospitalized elderly patients. BMC Geriatr 14:64
11. Takada N, Abe T, Shinohara N et al (2012) Peri-operative morbidity and mortality related to radical cystectomy: a multi-institutional retrospective study in Japan. BJU Int 110:E756–E764
12. Shabsigh A, Korets R, Vora KC et al (2009) Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 55:164–174
13. Eisenberg MS, Boorjian SA, Cheville JC et al (2013) The SPARC score: a multifactorial outcome prediction model for patients undergoing radical cystectomy for bladder cancer. J Urol 190:2005–2010
14. Ficarra V, Dalpiaz O, Alrabi N et al (2005) Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma. BJU Int 95:786–790
15. Djaladat H, Bruins HM, Miranda G et al (2014) The association of preoperative serum albumin level and American Society of Anesthesiologists (ASA) score on early complications and survival of patients undergoing radical cystectomy for urothelial bladder cancer. BJU Int 113:887–893
16. Boorjian SA, Kim SP, Tollefson MK et al (2013) Comparative performance of comorbidity indices for estimating perioperative and 5-year all cause mortality following radical cystectomy for bladder cancer 190:55–60
17. Gondo T, Nakashima J, Ohno Y et al (2012) Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy. Urology 79:1085–1091
18. Sejima T, Morizane S, Yao A et al (2014) Prognostic impact of preoperative hematological disorders and a risk stratification model in bladder cancer patients treated with radical cystectomy. Int J Urol 21:52–57
19. Willems JM, Vlasveld T, Den Elzen WP et al (2013) Performance of Cockcroft-Gault, MDRD, and CKD-EPI in estimating prevalence of renal function and predicting survival in the oldest old. BMC Geriatr 13:113
20. Ploussard G, Shariat SF, Dragomir A et al (2014) Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time. Eur Urol 66:361–370
21. Karl A, Carroll PR, Gschwend JE et al (2009) The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer. Eur Urol 55:826–835